Status:
COMPLETED
Food Addiction Clinical Treatment Program
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Food Addiction
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
The purpose of this current study is to establish the feasibility of, and preliminary support for, a clinical treatment program utilizing interventions from various empirically supported treatments fo...
Detailed Description
To establish the feasibility of recruiting, enrolling, and treating individuals who meet criteria for FA in a group behavioral intervention for 16 weeks. Data from the current study will be used for t...
Eligibility Criteria
Inclusion
- Age \> 25
- BMI \>25
- YFAS \> 6/11 (severe range)
- willing to commit to a 16 week group therapy program from 4 - 5:30 pm on Thursdays in Winston-Salem, NC
- English speaking
Exclusion
- Current participation in professional weight loss program and unwillingness to suspend it for 16 weeks during treatment
- obesity medications with exception of diabetes medication with weight loss benefit (ie metformin),
- current nicotine use or substance use disorder (based on meeting the clinical cutoff for the Alcohol Use Disorders Identification Test and/or Cannabis Use Disorder Identification Test
- history of weight loss surgery,
- current/history of severe mental illness (\> 3 psychiatric hospitalizations since age 18,
- schizoaffective disorder, bipolar disorder, psychotic disorder, or personality disorder),
- current/history of lithium, abilify, saphris, vraylor, clozaril, latuda, zyprexa, seroquel, risperdal, or Geodon,
- current pregnancy or breastfeeding,
- prior diagnosis of anorexia nervosa, diagnosis of bulimia nervosa in the last 5 years,
- high currents rates of restrictive eating disorder symptoms based on the Eating Disorder Diagnosis Scale (EDDS; (i.e., any endorsement of vomiting or laxative/diuretic use to manage weight and endorsement of fasting or excessive exercise more than 2 or 3 times a week)
Key Trial Info
Start Date :
March 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 2023
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04373343
Start Date
March 21 2023
End Date
September 7 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States, 27157